Senores Pharmaceuticals

INE0RB801010 · ISIN INE0RB801010 · 1 filing, FY 2025-26 to FY 2025-26 · standalone basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

CategoryFY 2025-26
Plastics including packaging not filed
E-waste not filed
Hazardous waste not filed
Other waste not filed
Total reclaimed 0

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products 21.54%
46497 Wholesale of pharmaceutical and medical goods 46.92%
7020 Management consultancy activities 8.16%
7210 Research and experimental development on natural sciences and engineering 22.49%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2025-26 Standalone 2026-02-28 1,06,09,00,000

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error